Back to School: How biopharma can reboot drug development. Access exclusive analysis here

House passes reimportation bill

The House of Representatives voted 243-186 on Friday to pass legislation mandating the reimportation of FDA-approved drugs, despite strong opposition

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE